7 ms·

Radical Vaccine Design Effective Against Herpes Viruses

65 points by alexcasalboni 12y ago

dzdt 12y ago
See http://liveherpesvaccine.com/category/herpes-immunology/ http://liveherpesvaccine.com/category/herpes-immunology/ for a long-running detailed blog by a different scientist who has been working on similar ideas for years. He has shown that a mutated HSV virus which is not capable of causing clinical disease (but which does cause a lifelong infection by the "harmless" version) protects against the dangerous version. This new research seems to be in the same vein: > When introduced to a mouse, HSV-2 was able to use the HSV-1 gD to enter the mouse’s cells. Once inside, HSV-2 replicated abundantly, but because it could not produce gD, future progeny were unable to infect new cells. According to Herold, infected cells then became “little factories for making viral proteins” that spurred the immune system to produce antibodies to HSV-2. That sounds like some cells are infected with the mutated virus and this remains as a lifelong infection. So far there seems little hope that the FDA would approve such an approach, based on Halford's experience. (See linked blog.)
- ianlevesque 12y ago
  I thought this was how the modern measles vaccine also functions though?
  - dzdt 12y ago
    You made me curious, so I did some reading. As far as I understand, the measles does use a live attenuated virus, but the resulting infection is not (normally) persistent. However, the varicella vaccine (chickenpox) DOES use a live attenuated virus that causes persistent infection.
iterationx 12y ago
According to the article: " Also, babies born to mothers with active genital herpes have a more than 80 percent mortality rate" How can this be if 1/6 people has herpes in the US ? Seems like you would hear about a lot more infant deaths.
- brohee 12y ago
  The infection is asymptomatic in most cases, the sentence clearly applies to people for which it is not, and during outbreaks...
- onion2k 12y ago
  The key word is "active". 1/6 of people have the virus, but far fewer have it an active outbreak at any given time.
  - refurb 12y ago
    In addition, if a mother has an active infection, you can deliver the baby via c-section to avoid passing the disease onto the kid.
- deleted 12y ago
  [deleted]
- dguaraglia 12y ago
  The amount of FUD being spread about HPV is stunning. Maybe it's my tinfoil hat, but I can only associate the increased news coverage on the fact that: 1) A pharmaceutical corporation developed a vaccine for it 2) TV broadcasting is heavily funded by pharmaceutical corporations 3) Profit It's brilliant. You develop a vaccine for a virus most of the population will be exposed to at some point in their lives (HPV, flu, you name it.) Despite the fact that the vast majority will survive the infection without any issues, you convince them that they'll die if they don't get vaccinated. Better yet: you convince them their kids will die. Rinse, repeat.
  - refurb 12y ago
    I think you're confused. HPV is not herpes. HPV (certain strains) is the leading cause of cervical cancer, oral cancer, anal cancer. Having a vaccine against it is a huge benefit to public health. I think pharma companies should be commended for developing it, considering the vaccine hasn't been selling that well and they certainly aren't making money had over fist with it.
nsxwolf 12y ago
So this wouldn't suppress existing infections? That seemed to be implied by other HSV vaccine approaches.
- arto 12y ago
  > The robust response generated by the vaccine, as well as its novel mechanism, has the researchers undertaking additional experiments in mice to determine whether it can be used to treat individuals already infected by HSV-1 and HSV-2.
perlgeek 12y ago
This may be a bit off-topic, but it's always hard for me to judge the trustworthiness and impact of such publications. Here at least was link to the journal publication (http://elifesciences.org/content/4/e06054 http://elifesciences.org/content/4/e06054), and http://en.wikipedia.org/wiki/ELife http://en.wikipedia.org/wiki/ELife says about the journal that it's a fairly recent (but afaict, well-backed) journal with impact factor 8.5. I know that in physics, an impact factor of 8.5 is really good, and http://impactfactor.weebly.com/medicine.html http://impactfactor.weebly.com/medicine.html lists only a few journals with a higher impact. So my first conclusion would be "not a scam". What else could I do to quickly get a feeling for how profound and trustworthy this is, in a field that I know next to nothing about?
- yungchin 12y ago
  Elife is backed by the largest non-profit funding medical research in the United Kingdom (the Wellcome Trust). Its editor won a Nobel Prize recently. I know these are somewhat shallow proxies for trustworthiness, but good enough for me ;) (As for the more general question - how do you decide this in general, in a field you're new to - I don't know. Probably asking in a thread on HN is a very good strategy actually :))
- toufka 12y ago
  In particular here - this is very real work, published in a very good journal (if brand new (One of the very few excellent Open Access Journals)). In regards to your question about how to get a gut feeling - it's not easy. Reputation is still important in the scientific community - reputation of the university/department, of the lead authors, and of the co-authors, and the journal itself. If they're names you recognize, it's not to say that it will automatically be trustworthy- but the likelihood is much greater. Reading the abstract of the actual paper, and seeing how well it comports with the article is another good measure. Oftentimes the abstract will be in significantly less flowery terms, as there are so very very few scientific papers that are flat out, very-first, discoveries. All come from their predecessors, and come with caveats. Finally - science is slow (compared to news cycles). So best bet is to just wait, ask around, and talk with people who have an interest in the field.
fsargent 12y ago
Does this work if you already have HSV-1 (but not HSV-2)? When can I get it? Can I make it at home?

65 points by alexcasalboni 12y ago

dzdt 12y ago

See http://liveherpesvaccine.com/category/herpes-immunology/ http://liveherpesvaccine.com/category/herpes-immunology/ for a long-running detailed blog by a different scientist who has been working on similar ideas for years. He has shown that a mutated HSV virus which is not capable of causing clinical disease (but which does cause a lifelong infection by the "harmless" version) protects against the dangerous version. This new research seems to be in the same vein: > When introduced to a mouse, HSV-2 was able to use the HSV-1 gD to enter the mouse’s cells. Once inside, HSV-2 replicated abundantly, but because it could not produce gD, future progeny were unable to infect new cells. According to Herold, infected cells then became “little factories for making viral proteins” that spurred the immune system to produce antibodies to HSV-2. That sounds like some cells are infected with the mutated virus and this remains as a lifelong infection. So far there seems little hope that the FDA would approve such an approach, based on Halford's experience. (See linked blog.)

ianlevesque 12y ago
I thought this was how the modern measles vaccine also functions though?
- dzdt 12y ago
  You made me curious, so I did some reading. As far as I understand, the measles does use a live attenuated virus, but the resulting infection is not (normally) persistent. However, the varicella vaccine (chickenpox) DOES use a live attenuated virus that causes persistent infection.

iterationx 12y ago

According to the article: " Also, babies born to mothers with active genital herpes have a more than 80 percent mortality rate" How can this be if 1/6 people has herpes in the US ? Seems like you would hear about a lot more infant deaths.

brohee 12y ago
The infection is asymptomatic in most cases, the sentence clearly applies to people for which it is not, and during outbreaks...
onion2k 12y ago
The key word is "active". 1/6 of people have the virus, but far fewer have it an active outbreak at any given time.
- refurb 12y ago
  In addition, if a mother has an active infection, you can deliver the baby via c-section to avoid passing the disease onto the kid.
deleted 12y ago
[deleted]
dguaraglia 12y ago
The amount of FUD being spread about HPV is stunning. Maybe it's my tinfoil hat, but I can only associate the increased news coverage on the fact that: 1) A pharmaceutical corporation developed a vaccine for it 2) TV broadcasting is heavily funded by pharmaceutical corporations 3) Profit It's brilliant. You develop a vaccine for a virus most of the population will be exposed to at some point in their lives (HPV, flu, you name it.) Despite the fact that the vast majority will survive the infection without any issues, you convince them that they'll die if they don't get vaccinated. Better yet: you convince them their kids will die. Rinse, repeat.
- refurb 12y ago
  I think you're confused. HPV is not herpes. HPV (certain strains) is the leading cause of cervical cancer, oral cancer, anal cancer. Having a vaccine against it is a huge benefit to public health. I think pharma companies should be commended for developing it, considering the vaccine hasn't been selling that well and they certainly aren't making money had over fist with it.

nsxwolf 12y ago

So this wouldn't suppress existing infections? That seemed to be implied by other HSV vaccine approaches.

arto 12y ago
> The robust response generated by the vaccine, as well as its novel mechanism, has the researchers undertaking additional experiments in mice to determine whether it can be used to treat individuals already infected by HSV-1 and HSV-2.

perlgeek 12y ago

This may be a bit off-topic, but it's always hard for me to judge the trustworthiness and impact of such publications. Here at least was link to the journal publication (http://elifesciences.org/content/4/e06054 http://elifesciences.org/content/4/e06054), and http://en.wikipedia.org/wiki/ELife http://en.wikipedia.org/wiki/ELife says about the journal that it's a fairly recent (but afaict, well-backed) journal with impact factor 8.5. I know that in physics, an impact factor of 8.5 is really good, and http://impactfactor.weebly.com/medicine.html http://impactfactor.weebly.com/medicine.html lists only a few journals with a higher impact. So my first conclusion would be "not a scam". What else could I do to quickly get a feeling for how profound and trustworthy this is, in a field that I know next to nothing about?

yungchin 12y ago
Elife is backed by the largest non-profit funding medical research in the United Kingdom (the Wellcome Trust). Its editor won a Nobel Prize recently. I know these are somewhat shallow proxies for trustworthiness, but good enough for me ;) (As for the more general question - how do you decide this in general, in a field you're new to - I don't know. Probably asking in a thread on HN is a very good strategy actually :))
toufka 12y ago
In particular here - this is very real work, published in a very good journal (if brand new (One of the very few excellent Open Access Journals)). In regards to your question about how to get a gut feeling - it's not easy. Reputation is still important in the scientific community - reputation of the university/department, of the lead authors, and of the co-authors, and the journal itself. If they're names you recognize, it's not to say that it will automatically be trustworthy- but the likelihood is much greater. Reading the abstract of the actual paper, and seeing how well it comports with the article is another good measure. Oftentimes the abstract will be in significantly less flowery terms, as there are so very very few scientific papers that are flat out, very-first, discoveries. All come from their predecessors, and come with caveats. Finally - science is slow (compared to news cycles). So best bet is to just wait, ask around, and talk with people who have an interest in the field.

fsargent 12y ago

Does this work if you already have HSV-1 (but not HSV-2)? When can I get it? Can I make it at home?